RecruitingPhase 3NCT05879926Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Sponsor: NRG OncologyAmes, IA · Ankeny, IA · +1223 more sites
RecruitingPhase 3NCT05812807Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus PembrolizumabSponsor: Alliance for Clinical Trials in OncologyAnkeny, IA · Bettendorf, IA · Carroll, IA · +825 more sites
RecruitingPhase not listedNCT02012699Integrated Cancer Repository for Cancer ResearchSponsor: University of NebraskaCouncil Bluffs, IA · Waterloo, IA · +40 more sites
RecruitingPhase 3NCT05929768Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast CancerSponsor: SWOG Cancer Research NetworkAmes, IA · Ankeny, IA · +952 more sites